Equity Research, Broker Reports, and media content on HemoGenyx Pharmaceuticals Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about HemoGenyx Pharmaceuticals Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard
HemoGenyx

HemoGenyx Pharmaceuticals Plc

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on HemoGenyx Pharmaceuticals Plc. We currently have 46 research reports from 4 professional analysts.

Date Source Announcement
28Mar24 07:00 RNS Hemogenyx Pharma Plc - Total Voting Rights
29Feb24 07:00 RNS Hemogenyx Pharma Plc - Placing to Raise US$4.2 million
16Feb24 07:00 RNS Hemogenyx Pharma Plc - CBR Brain Delivery
14Feb24 07:00 RNS Hemogenyx Pharma Plc - CBR Intranasal Delivery
09Feb24 07:00 RNS Hemogenyx Pharma Plc - FDA Consents to Phase I Trials of HEMO-CAR-T
02Feb24 07:00 RNS Hemogenyx Pharma Plc - Approval and Issuance of U.S. Conditioning Patent
16Jan24 07:00 RNS Hemogenyx Pharma Plc - Submission of Complete Response to Clinical Hold
  • Frequency of research reports

     

  • Research reports on

    HemoGenyx Pharmaceuticals Plc

  • Providers covering

    HemoGenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals Plc is a preclinical-stage biotechnology company. The company trades under the ticker Lon:HEMO